IQ Medical Services

EANM 2024 has come to a close, and what an amazing time we had in Hamburg! We were thrilled to connect with our valued customers, industry partners, and dear friends at the European Association of Nuclear Medicine annual meeting. Our team had a fantastic experience engaging with clients and attending insightful educational sessions, all aimed at learning from the vibrant nuclear medicine community. It’s always a pleasure to engage in meaningful discussions about how our modality enhances patient care and to witness the rapid advancements in the industry that are driving improved outcomes. Thank you to everyone who made this event memorable - until next year! #EANM24

It’s Nuclear Medicine and Molecular Imaging Week! Our groundbreaking advancements in nuclear medicine are transforming patient care, from early diagnosis to targeted therapy. From imaging techniques that provide unparalleled insights into the body's inner workings to therapies that deliver precise treatments to disease sites, our industry is revolutionizing healthcare. Let's continue to collaborate, innovate, and push the boundaries of what's possible. Together, we can shape the future of medicine and improve the lives of countless patients. #NMWeek #SeeItTreatItBelieveIt

As we commemorate #WorldCancerResearchDay on September 24th, let's celebrate the remarkable strides made in nuclear medicine and theranostics. These advancements, driven by relentless research, are revolutionizing cancer care. Through the development of innovative radiopharmaceuticals, we’re unlocking new possibilities for precision diagnosis and targeted treatment. Our dedication to pushing the boundaries of science reflects our unwavering commitment to improving patient outcomes and shaping a future where cancer is a treatable disease. Join us in honoring the researchers, clinicians, and innovators who are at the forefront of this medical revolution. Together, we can continue to break down barriers, accelerate discoveries, and bring hope to countless individuals affected by cancer. #cancerresearch

Excited to share a recent achievement! At IQ Medical Services, we had the privilege of working with Hospital Muguerza in Monterrey, Mexico, on a key project for radiopharmaceutical production. Our team handled the installation of hot cells, QC equipment, IOQ and PQ, culminating in the process validation (PV) for FDG production. A special thanks to our project manager, Federico Díaz, whose meticulous eye was always overseeing every step of the process. A heartfelt thank you to our hosts at Hospital Muguerza for their exceptional hospitality during our stay. It made all the difference! María Patricia Acosta Mariño Antonio De León Saray Soto Arévalo Daniela Padilla Hugo Solis This project is a significant step forward in our mission to deliver high-quality solutions for radiopharmaceutical production. #IQMS #Healthcare #Radiopharmacy #FDG #Muguerza #Cyclotron #Quality #Projectmanagement

Excited to share a recent achievement! At IQ Medical Services, we had the privilege of working with Hospital Muguerza in Monterrey, Mexico, on a key project for radiopharmaceutical production. Our team handled the installation of hot cells, QC equipment, IOQ and PQ, culminating in the process validation (PV) for FDG production. A special thanks to our project manager, Federico Díaz, whose meticulous eye was always overseeing every step of the process. A heartfelt thank you to our hosts at Hospital Muguerza for their exceptional hospitality during our stay. It made all the difference! María Patricia Acosta Mariño Antonio De León Saray Soto Arévalo Daniela Padilla Hugo Solis This project is a significant step forward in our mission to deliver high-quality solutions for radiopharmaceutical production. #IQMS #Healthcare #Radiopharmacy #FDG #Muguerza #Cyclotron #Quality #Projectmanagement

Ocorreu nos últimos dias 11/09/2024 e 12/09/2024 o I Simpósio de Imagem Molecular do LIM-43 do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Neste evento celebramos os 10 anos da obtenção da primeira imagem molecular com PET/CT utilizando biomarcador de proteína amilóide no Brasil, com especial foco na avaliação de pacientes com processos neurodegenerativos , com destaque para a doença de Alzheimer. O evento contou com a participação de ilustres convidados nacionais e internacionais, dentre os quais destacamos o Prof. Eduardo Zimmer da Universidade Federal do Rio Grande do Sul, Profa. Danielle Macêdo Gaspar da Universidade Federal do Ceará , Prof. David Jones da Mayo Clinic, Rochester, Minnesota - Estados Unidos, Prof. Juan Fortea do Hospital de la Santa Creu i Sant Pau de Barcelona - Espanha, e o Prof. Tharick Pascoal da Universidade de Pittsburgh, Pensilvânia - Estados Unidos. Tivemos a honra e oportunidade de contar com a participação do Prof. Marco Antônio Zago que é o atual Presidente da FAPESP e da Profa. Stefania Forner que é Diretora da Alzheimer’s Association nos EUA , que conversaram com os jovens estudantes e cientistas sobre as múltiplas oportunidades de funding para pesquisa. Não poderia deixar de fazer também um especial agradecimento a toda equipe que proporcionou esse desenvolvimento nos últimos dez anos e que participou como Comitê Organizador deste evento , representados pela Profa. Daniele de Paula Faria, Prof. Artur Martins N. Coutinho , Prof. Marcelo T. Sapienza, Miriam Okamoto representando toda a equipe do CinRad, e sem esquecer nosso grande parceiro de tantos anos e que foi essencial para atingirmos juntos esse marco, Prof. Geraldo Busatto. Aproveitamos também para fazer um especial agradecimento a nossos parceiros e patrocinadores, GE HealthCare , IQ Medical Services, CMR Pharma e USP - Universidade de São Paulo . Nossa missão em estimular a pesquisa em neurociências e estimular uma brilhante geração de novos valores que estão distribuídos nos diferentes departamentos da nossa Universidade e pelo Brasil afora, e reter valores que já se destacam atuando na academia continua e nos preenche de enorme orgulho e emoção. Que venha o II Simpósio de Imagem Molecular do LIM-43 do HCFMUSP em 2026.

This past week, Hernan Lara and Tiago Scott Hood had an incredible experience at the 38th Annual Congresso Brasileiro de Medicina Nuclear SBMN in São Paulo, Brazil. It was inspiring to see the evolution of Nuclear Medicine in Brazil and the increasing interest from pharma companies in the Brazilian market.   A standout moment was participating in the tribute, "Homenagem," to Edson Roman during the opening ceremony. Edson, a valued partner and friend of IQ Medical Services, received a well-deserved standing ovation for his significant contributions to the growth of nuclear medicine industry, including the building of the largest private cyclotron network in Brazil and in Latin America. Being part of this special event was truly memorable. #NuclearMedicine #HealthcareInnovation #Pharma #Brazil #Networking #MedicalCommunity #SBNM

Novartis has announced plans to expand its radioligand therapy (RLT) manufacturing capacity in the United States. The company will construct two new facilities to enhance its in-house manufacturing capabilities and ensure a reliable supply chain for these crucial therapeutics. Construction has commenced at Novartis' Indianapolis site, where a new facility will be built to produce radioisotopes essential for RLT manufacturing. Additionally, the company is establishing a third RLT manufacturing site in Carlsbad, California that will support the growing demand for RLTs, strengthen the manufacturing network, and optimize the delivery of drugs to patients in the western United States. #RLT #supplychain

Life Molecular Imaging and the University of Wisconsin Alzheimer's Disease Research Center (ADRC) have established a collaborative agreement to support the National Institute on Aging's (NIA) Consortium for Clarity in ADRD Research Through Imaging (CLARiTI) study. This partnership will provide CLARiTI investigators with access to Neuraceq and fluorine-18 [18F]-PI-2620 at all Alzheimer's Disease Research Centers across the United States, facilitating the advancement of Alzheimer's disease research. #AlzheimersDisease

Our team is here in Valledupar, Colombia for the XIX Congreso Colombiano de Medicina Nuclear! We’re looking forward to connecting with the Nuclear Medicine community and learning about the latest advances in patient care throughout Latin America. Stop by our booth to learn more about our expertise in global radiopharmacy solutions! #ACMNIM #IQMedicalServices